Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.
The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent. There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.
Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation. It is also included in treatment regimens for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old – the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.
The mice were examined with ultrasound echocardiography before and after the three-month treatment period – using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related cardiac dysfunction was either slowed or reversed in the treated mice. “When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period,” he said. “This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment,” added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.
Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. “Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation,” said Melov. “We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention.”
“Little has been known about the functional ramifications of rapamycin in mammalian tissues,” said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. “These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life.” He added, “It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life.”
The Latest Bing News on:
Age-Related Heart Disease
- Heart disease: How the DASH diet can help lower the risk after breast cancer treatmenton April 17, 2024 at 1:03 am
Researchers say women who've been treated for breast cancer can lower their risk of cardiovascular disease by following the DASH and other healthy diets ...
- Coronary Heart Disease and Pregnancyon April 15, 2024 at 5:00 pm
Since women are delaying childbearing until older age, acute coronary syndrome ... the available information about pregnancy-related coronary heart disease. Yusuf Karamermer, Thorax Center ...
- Exercise changes the brain in a way that helps heart health, especially for people with depressionon April 15, 2024 at 2:32 pm
Research has long shown that exercise reduces heart disease risk, but a new study finds the connection between the two may be a decrease in the brain’s stress signals.
- Fitterfly Launches FitHeart - A Clinically Proven Digital Program for Improving Heart Age & Heart Healthon April 7, 2024 at 11:02 pm
Heart disease is a growing concern in India, with more than 22 crore people affected by hypertension and other heart ailments. Finding affordable, reliable, and accessible heart care is a challenge.
- How exercise might help prevent DNA damage, age-related vascular issueson April 5, 2024 at 10:30 am
A study conducted in male mice suggests that regular exercise may help protect against cardiovascular issues that come with aging by preventing DNA damage.
- The Black community, heart valve disease, socioeconomic factors influencing the health care systemon April 5, 2024 at 10:24 am
Learn about the disproportionate impact of racism on heart valve disease in Black Americans. Explore risk factors, symptoms, and preventative measures.
- SGLT2 Inhibitors Safe for HF in Congenital Heart Diseaseon April 5, 2024 at 4:52 am
SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations.
- Valvular Heart Disease Associated With AMD Subseton April 3, 2024 at 5:00 pm
The subretinal drusenoid deposit form of age-related macular degeneration (AMD) was found to be associated with valvular heart disease as well as cardiac index. The subretinal drusenoid deposit ...
- Women's heart disease risk can rise sharply after menopause, a new study finds. Here's what to know.on April 1, 2024 at 5:00 pm
Women’s heart health may decline precipitously after going through menopause, a new study suggests. On average, men are more likely to have a heart attack at a younger age. The average age of a ...
- More than one alcoholic drink a day raises heart disease risk for womenon March 28, 2024 at 6:55 am
but this study shows that even in that age group, women who drink more than the recommended amount of one drink per day or tend to binge drink, are at risk for coronary heart disease,” Jamal ...
The Latest Google Headlines on:
Age-Related Heart Disease
[google_news title=”” keyword=”Age-Related Heart Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Rapamycin
- Rare and Unusual Clinical Presentations of Gouton April 19, 2024 at 7:29 am
Numerous case reports have described a wide array of atypical gout affecting nearly every organ, including the spine, skin, nose, and scrotum, among others.
- Book Review: A New Chapter in the Quest for a Longer Lifeon April 19, 2024 at 12:53 am
In “Why We Die,” biologist and Nobel laureate Venki Ramakrishnan explores the science of aging and life extension.
- Rapamycin: The Drug with a Potential to Extend Life and Combat Age-Related Diseaseson April 18, 2024 at 12:07 pm
Rapamycin, a drug traditionally used to prevent organ transplant rejection, has garnered attention for its potential as a longevity enhancer and a combatant against age-related diseases. The ...
- For Secrets to Extending Human Lives, Keep the Dog Aging Project Aliveon April 16, 2024 at 10:00 pm
It was never only about the dogs. It’s always been about people too – and our need to extend health and well-being now that we’ve devised so many ways to keep ourselves alive longer.
- The role of TOR signaling in enhancing graft success and crop vigoron April 16, 2024 at 11:24 am
A research team has delved into the Target of Rapamycin (TOR) signaling pathway in plant grafting, emphasizing its role in regulating seedling vigor, graft junction healing, and shoot-to-root ...
- Social Media Claims This FDA-Approved Pill Can Slow Down Aging. Can It?on April 16, 2024 at 12:00 am
And people are turning to medication to slow aging, too. Some medical professionals and social media influencers claim that rapamycin, a pill that’s approved by the Food and Drug Administration for ...
- Dogs Die Too Soon, but a Possible Drug Could Fix Thaton April 15, 2024 at 6:30 am
Two clinical trials and a huge observational study hope to extend and improve the lives of dogs.
- How to Die in Good Healthon April 15, 2024 at 3:00 am
The average American celebrates just one healthy birthday after the age of sixty-five. Peter Attia argues that it doesn’t have to be this way.
- Top 6 Best Rapamycin Supplements in 2024on March 26, 2024 at 5:00 pm
Rapamycin is a naturally occurring compound that has exhibited anti-aging and health advantages in numerous studies. As a result, the demand for rapamycin supplements has skyrocketed in recent years.
- How a cheap, generic drug became a darling of longevity enthusiastson March 15, 2024 at 12:55 pm
To keep himself healthy into his eighth decade, David Sandler recently decided to go beyond his regular workouts and try something experimental: taking rapamycin, an unproven but increasingly popular ...
The Latest Google Headlines on:
Rapamycin
[google_news title=”” keyword=”rapamycin ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]